1) Uroplakin
尿路上皮特异蛋白
1.
Uroplakin Ⅱ gene in transitional cell carcinoma of the bladder;
膀胱癌患者尿路上皮特异蛋白Ⅱ基因的表达
2) urothelium
[,juərəu'θi:liəm]
尿路上皮
1.
Objective To establish immortalized cell line from the urothelium of the urinary bladder and identify the characteristics of the cell line.
目的建立膀胱尿路上皮永生化细胞系,并初步鉴定其生物学特性。
3) specific oviductal epithelial glycoprotein
输卵管上皮特异性糖蛋白
4) urothelial cancer
尿路上皮癌
1.
Expression of KAI1 in urothelial cancer tissues and its relationship with invasion and metastasis of urothelial cancer;
KAI1在尿路上皮癌组织中的表达及其与浸润转移的关系
2.
To evaluate the clinical value of NMP22 for the diagnosis of urothelial cancer.
评估尿核基质蛋白 2 2 (NMP2 2 )作为尿路上皮癌肿瘤标记物的临床诊断价值。
5) Urothelial carcinoma
尿路上皮癌
1.
Telomerase activity in urine in diagnosis and recurrence surveillance of urothelial carcinoma;
尿液中端粒酶活性在尿路上皮癌的诊断及监测复发中的意义(英文)
2.
Analysis of the clinicopathological characteristics of patients with upper tract urothelial carcinoma
26例上尿路上皮癌临床病理分析
3.
BACKGROUND & OBJECTIVE: Urothelial carcinoma of the urinary bladder is a common malignant neoplasm of the genitourinary system.
背景与目的:膀胱尿路上皮癌是我国泌尿生殖系统常见的恶性肿瘤。
6) uroepithelium carcinoma
尿路上皮癌
1.
Expressions of Survivin,p53 and bcl-2 in uroepithelium carcinoma and their clinical significance;
尿路上皮癌中Survivin,p53,bcl-2的表达及意义
2.
Objective: To investigate the expressions of Survivin、p53 and bcl-2 in uroepithelium carcinoma tissues, and their correlations with uroepithelium tumor malignancy.
目的:探讨Survivin、p53、bcl-2在尿路上皮癌组织中的表达及其与肿瘤恶性程度之间的相关性。
补充资料：肝细胞特异性脂蛋白抗体
肝细胞特异性脂蛋白抗体
liver cell specific lipoprotein antibody,LSP
肝细胞特异性脂蛋白(LSP)的特异性抗体。用LSP单克隆抗体B2作ELISA检测，只与肝起反应，与肾、胃、甲状腺、胰腺等不起反应。慢性活动性肝炎血清中抗LSP检出率很高，且与疾病活动程度密切相关；急性病毒性肝炎阳性率也较高，但恢复期即转阴。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条